110P London, UK
Pharmacology 2017

 

 

Trypsin-induced contractile responses are enhanced in permeabilized detrusor smooth muscle in a rat model of cystitis

I. Anjum1, M. Denizalti1, G. Simsek2,N. T. Durlu-Kandilci11Department of Pharmacology, Hacettepe University, Ankara, Turkey, 2Department of Biophysics, Ankara University, Ankara, Turkey.

Introduction: Protease-activated receptors (PAR1,2,3,4) belong to G-protein coupled receptor family. Trypsin causes smooth muscle contraction via PAR2 receptors, both in physiological and pathological situations.1,2,3 It has been shown that activation of PAR2 stimulates release of prostaglandins from mucosal layer and thereby contracts bladder smooth muscle2. Furthermore, trypsin-induced contractions were increased in cystitis without any change in PAR2receptor expression, but in detrusors with urothelium3. In the present study, The intracellular mechanisms of trypsin-induced contractile response were investigated in permeabilized detrusor smooth muscle of rats without urothelium, in a model of cystitis.

Method: The study protocol was approved by the University Animal Ethics Committee (2016/07-06). Cyclophosphamide (150 mg/kg) was injected to rats (Sprague-Dawley, female, 200-250g) intraperitoneally once a day on days 1, 4 and 7 to induce cystitis. Control group was injected with saline (NaCl 0.9 %) using the same protocol. Detrusor smooth muscle strips (urothelium denuded) were mounted in 1 ml organ baths containing modified Krebs\' solution. Tissues were permeabilized with 40 μM β-escin for 30 min. Isometric contractions were expressed as % of 80 mM K+. PARreceptor protein levels were determined by Western blotting. Data were given as mean±S.E.M. P<0.05 was accepted as significant.

Results: Trypsin (1 mM)-induced contractile responses were increased from 10±1% (control,n=6) to 14±1% in cystitis (P<0.05,n=7). These contractions were inhibited 60% by PAR2receptor antagonist ENMD-1068 (5mM) in control. PARreceptor protein expression was also increased 30% in cystitis (compared to control,P<0.05,n=3-4). Trypsin-induced contractions were inhibited 40% by sarcoplasmic reticulum IP3 receptor blocker heparin (1mg/ml) in control where 64% in cystitis (P<0.05,n=6). Moreover, contractions were inhibited 70% by sarcoplasmic reticulum ryanodine channel blocker ryanodine (10mM) in control but 35% in cystitis (n=4). Contractions were decreased to 7±1% in control and to 9±1% in cystitis by Rho kinase inhibitor Y-27632 (1μM) (P<0.05,n=5-7). These responses were also attenuated by protein kinase C inhibitor GF-109203X (5μM) in both groups, 5±1% in control and 8±1% in cystitis (P<0.05,n=6).

Conclusion: Our findings provide the first evidence that cystitis increases trypsin-induced contractions in permeabilized detrusor smooth muscle of rats. The augmentation in trypsin-induced contractions via PAR2 receptors in cystitis involves an increase in intracellular calcium release from sarcoplasmic reticulum and moreover an activation in both Rho kinase and protein kinase C pathways.

References:

1. Kubota et al. (2003). Naunyn-Schmiedeberg’s Arch Pharmacol 367: 588-591.

2. Nakahara et al. (2003). Naunyn-Schmiedeberg’s Arch Pharmacol 367: 211-213.

3. Nakahara et al. (2004). Naunyn-Schmiedeberg’s Arch Pharmacol 369: 212-219.